Land: Storbritannien
Sprog: engelsk
Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Nicotine
McNeil Products Ltd
N07BA01
Nicotine
500microgram/1dose
Spray
Nasal
No Controlled Drug Status
Valid as a prescribable product
BNF: 04100200; GTIN: 5012882005924
NASAL SPRAY NICOTINE NASAL SPRAY SOLUTION WHAT YOU SHOULD KNOW ABOUT NICORETTE ® NASAL SPRAY (10 ml nasal spray containing nicotine 10 mg/ml) Please read this leaflet carefully before you start using this medicine. It provides useful information on how to use it safely. Keep the leaflet, you might need it again. If you think you are having side-effects, have any questions or are not sure about anything please ask your doctor, nurse or pharmacist. 1 WHAT THIS MEDICINE IS FOR NICORETTE ® Nasal Spray is a nicotine replacement therapy (NRT). It is used to relieve withdrawal symptoms and reduce the cravings for nicotine that you get when you try to stop smoking. To help quit smoking you should also try to use a behavioural support programme to increase your chances of success. WHAT DOES NICORETTE ® NASAL SPRAY DO? When you stop smoking, your body misses the nicotine that you have been absorbing. You may experience unpleasant feelings and a strong desire to smoke (craving). This indicates that you were dependent on nicotine. When you spray NICORETTE ® Nasal Spray into your nose, nicotine passes rapidly into your body through the lining of your nose. The nicotine released is sufficient to relieve the unpleasant nicotine withdrawal symptoms. It will also help to stop your craving to smoke but will not give you the “buzz” you get from smoking a cigarette. The benefits of stopping smoking far outweigh any potential risk from using nicotine from NRT. It is the toxins in cigarette smoke such as tar, lead, cyanide and ammonia that cause smoking related disease and death, not the nicotine. 2 BEFORE USING THIS MEDICINE DO NOT USE NICORETTE ® NASAL SPRAY: n if you have an allergy to nicotine or any of the other ingredients. ! TALK TO YOUR DOCTOR, NURSE OR PHARMACIST… n if you are pregnant or breast-feeding – you may be able to use nicotine replacement therapy (NRT) to help you give up smoking but you should try to give up without it. See “_If you _ _are pregnant or breast-feeding_” section. n if you are in hospi Læs hele dokumentet
OBJECT 1 NICORETTE NASAL SPRAY Summary of Product Characteristics Updated 19-Jul-2016 | McNeil Products Ltd 1. Name of the medicinal product Nicorette Nasal Spray Boots NicAssist 10 mg/ml Nasal Spray 2. Qualitative and quantitative composition Nicotine 10 mg/ml. Each spray of 50 µl delivers 0.5 mg nicotine. For excipients see section 6.1 3. Pharmaceutical form Nasal Spray, solution. 4. Clinical particulars 4.1 Therapeutic indications Nicorette Nasal Spray is indicated for the relief of nicotine withdrawal symptoms as an aid to smoking cessation in adults and children over 12 years of age. It is also indicated in pregnant and lactating women (see section 4.6). If possible, Nicorette Nasal Spray should be used in conjunction with a behavioural support programme. 4.2 Posology and method of administration The patient should make every effort to stop smoking completely during treatment with Nicorette Nasal Spray. Behavioural therapy, advice and support will normally improve the success rate. This product must only be used with other NRT products under the advice of a healthcare professional. Directions for use 1) Remove the protective cap. 2) Prime Nicorette Nasal Spray by placing the nozzle between first and second finger with the thumb on the bottom of the bottle. Press several times firmly and quickly until a fine spray appears (up to 7-8 strokes). Important: Point the spray safely away when priming it. Do not prime it near children or pets. 3) Insert the spray tip into one nostril, pointing the top towards the back of the nose. Press firmly and quickly. Give a spray into the other nostril. 4) Put on the protective cap Adults (over 18 years of age) 1. The frequency of use depends on the previous smoking habit of the individual and the level of their nicotine dependence. 2. On commencing treatment the patient uses the spray to treat craving as required, subject to a limit of one spray to each nostril twice an hour. 3. A 50 µl dose of solution is sprayed into the nostril when the unit is activated. This is describe Læs hele dokumentet